Alternatively, these drugs may act independently of estrogen receptor and have a general anti-proliferative effect on breast cancer cells, as suggested by the fact that they also inhibit proliferation of tamoxifen sensitive MCF-7 cells. This evidence concerns the gene ESR1 and breast carcinoma.